OrthoPediatrics (KIDS) Competitors

OrthoPediatrics (NASDAQ:KIDS) and National Vision (NASDAQ:EYE) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Which has stronger earnings & valuation, KIDS or EYE?

National Vision has higher revenue and earnings than OrthoPediatrics. National Vision is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$204.73M	2.54	-$37.82M	-$1.79	-11.57
National Vision	$1.82B	1.00	-$28.50M	-$0.18	-128.39

Do institutionals and insiders hold more shares of KIDS or EYE?

69.1% of OrthoPediatrics shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by company insiders. Comparatively, 2.7% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is KIDS or EYE more profitable?

National Vision has a net margin of -0.75% compared to OrthoPediatrics' net margin of -18.92%. National Vision's return on equity of 3.56% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-18.92%	-6.36%	-4.69%
National Vision	-0.75%	3.56%	1.49%

Does the media favor KIDS or EYE?

In the previous week, National Vision had 5 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for National Vision and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.60 beat National Vision's score of 1.33 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
National Vision	7 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, KIDS or EYE?

OrthoPediatrics has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Do analysts rate KIDS or EYE?

OrthoPediatrics presently has a consensus price target of $34.14, suggesting a potential upside of 64.86%. National Vision has a consensus price target of $24.73, suggesting a potential upside of 7.00%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, equities analysts clearly believe OrthoPediatrics is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
National Vision	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

OrthoPediatrics and National Vision tied by winning 8 of the 16 factors compared between the two stocks.